Association of hepatitis C infection and acute coronary syndrome: A case-control study
PublisherWolters Kluwer Health
MetadataShow full item record
AbstractInfections with hepatitis C virus (HCV) represent a substantial national and international public health burden. HCV has been associated with numerous extrahepatic conditions and can lead to metabolic derangements that are associated with atherosclerosis and cardiovascular disease. We investigated whether HCV infection is associated with an increased number of acute coronary syndrome (ACS) events among hospitalized patients in an inner-city tertiary hospital.We performed a matched (age, sex, and race/ethnicity) case-control study on patients at least 18 years old admitted to inpatient medical and cardiac services at the University of Maryland Medical Center from 2015 through 2018. The primary outcome was ACS and the primary exposure was HCV infection. Covariates of interest included: alcohol use, tobacco use, illicit drug use, hypertension, diabetes mellitus, human immunodeficiency virus infection, body mass index, dyslipidemia, and family history of coronary heart disease. Covariates with significant associations with both exposure and outcome in bivariate analyses were included in the multivariable analyses of the final adjusted model.There were 1555 cases and 3110 controls included in the final sample. Almost 2% of cases and 2.4% of controls were HCV infected. In adjusted models, there was no significant association found between experiencing an ACS event in those with HCV infection compared to those without HCV infection (odds ratio 0.71, 95% confidence interval 0.45-1.11).We found no significant association between HCV infection and ACS in our study population. However, given the mixed existing literature, the association between HCV and ACS warrants further investigation in future prospective cohort and/or interventional studies.
Rights/TermsCopyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
Keywordacute coronary syndrome
coronary heart disease
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/15906
- Platelet Reactivity in Hepatitis C Virus-Infected Patients on Dual Antiplatelet Therapy for Acute Coronary Syndrome.
- Authors: Scudiero F, Valenti R, Marcucci R, Sanna GD, Gori AM, Migliorini A, Vitale R, Giusti B, De Vito E, Corda G, Paniccia R, Zirolia D, Canonico ME, Parodi G
- Issue date: 2020 Sep 15
- Sexual Dimorphic Metabolic Alterations in Hepatitis C Virus-infected Patients: A Community-Based Study in a Hepatitis B/Hepatitis C Virus Hyperendemic Area.
- Authors: Hu JH, Chen MY, Yeh CT, Lin HS, Lin MS, Huang TJ, Chang ML
- Issue date: 2016 May
- Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients.
- Authors: Hsu YC, Lin JT, Ho HJ, Kao YH, Huang YT, Hsiao NW, Wu MS, Liu YY, Wu CY
- Issue date: 2014 Apr
- Hepatitis C virus infection and the risk of cancer among elderly US adults: A registry-based case-control study.
- Authors: Mahale P, Torres HA, Kramer JR, Hwang LY, Li R, Brown EL, Engels EA
- Issue date: 2017 Apr 1
- A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
- Authors: Zhang JY, Dai M, Wang X, Lu WQ, Li DS, Zhang MX, Wang KJ, Dai LP, Han SG, Zhou YF, Zhuang H
- Issue date: 1998 Aug